| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Cell, Tumor, and Stem Cell Biology |
B Activation by Astrocyte Elevated Gene-1Departments of 1 Urology, 2 Pathology, and 3 Neurosurgery, Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, College of Physicians and Surgeons, New York, New York; and 4 Department of Human Genetics, Massey Cancer Center, Medical College of Virginia, Virginia Commonwealth University, Richmond, Virginia
Requests for reprints: Devanand Sarkar, Massey Cancer Center, Virginia Commonwealth University, Richmond, VA 23298-0037. E-mail: dsarkar{at}vcu.edu and Paul B. Fisher, Massey Cancer Center, Virginia Commonwealth University, Richmond, VA 23298-0037. E-mail: pbfisher{at}vcu.edu.
Key Words: AEG-1, astrocyte elevated gene-1 NF-
B, nuclear factor
B PHFA, primary human fetal astrocytes Invasion Transcriptional regulation
Malignant glioma is a consistently fatal brain cancer. The tumor invades the surrounding tissue, limiting complete surgical removal and thereby initiating recurrence. Identifying molecules critical for glioma invasion is essential to develop targeted, effective therapies. The expression of astrocyte elevated gene-1 (AEG-1) increases in malignant glioma and AEG-1 regulates in vitro invasion and migration of malignant glioma cells by activating the nuclear factor-
B (NF-
B) signaling pathway. The present studies elucidate the domains of AEG-1 important for mediating its function. Serial NH2-terminal and COOH-terminal deletion mutants were constructed and functional analysis revealed that the NH2-terminal 71 amino acids were essential for invasion, migration, and NF-
B–activating properties of AEG-1. The p65-interaction domain was identified between amino acids 101 to 205, indicating that p65 interaction alone is not sufficient to mediate AEG-1 function. Coimmunoprecipitation assays revealed that AEG-1 interacts with cyclic AMP-responsive element binding protein–binding protein (CBP), indicating that it might act as a bridging factor between NF-
B, CBP, and the basal transcription machinery. Chromatin immunoprecipitation assays showed that AEG-1 is associated with the NF-
B binding element in the interleukin-8 promoter. Thus, AEG-1 might function as a coactivator for NF-
B, consequently augmenting expression of genes necessary for invasion of glioma cells. In these contexts, AEG-1 represents a viable potential target for the therapy of malignant glioma. [Cancer Res 2008;68(5):1478–84]
This article has been cited by other articles:
![]() |
D. Sarkar, L. Emdad, S.-G. Lee, B. K. Yoo, Z.-z. Su, and P. B. Fisher Astrocyte Elevated Gene-1: Far More Than Just a Gene Regulated in Astrocytes Cancer Res., November 15, 2009; 69(22): 8529 - 8535. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Hu, Y. Wei, and Y. Kang The Multifaceted Role of MTDH/AEG-1 in Cancer Progression Clin. Cancer Res., September 15, 2009; 15(18): 5615 - 5620. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. K. Yoo, R. Gredler, N. Vozhilla, Z.-z. Su, D. Chen, T. Forcier, K. Shah, U. Saxena, U. Hansen, P. B. Fisher, et al. Identification of genes conferring resistance to 5-fluorouracil PNAS, August 4, 2009; 106(31): 12938 - 12943. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Yu, K. Chen, H. Zheng, X. Guo, W. Jia, M. Li, M. Zeng, J. Li, and L. Song Overexpression of astrocyte elevated gene-1 (AEG-1) is associated with esophageal squamous cell carcinoma (ESCC) progression and pathogenesis Carcinogenesis, May 1, 2009; 30(5): 894 - 901. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z.-z. Su, S.-G. Lee, L. Emdad, I. V. Lebdeva, P. Gupta, K. Valerie, D. Sarkar, and P. B. Fisher Cloning and characterization of SARI (suppressor of AP-1, regulated by IFN) PNAS, December 30, 2008; 105(52): 20906 - 20911. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. de la Iglesia, G. Konopka, K.-L. Lim, C. L. Nutt, J. F. Bromberg, D. A. Frank, P. S. Mischel, D. N. Louis, and A. Bonni Deregulation of a STAT3-Interleukin 8 Signaling Pathway Promotes Human Glioblastoma Cell Proliferation and Invasiveness J. Neurosci., June 4, 2008; 28(23): 5870 - 5878. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |